Trade RadNet Inc - RDNT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.35
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022262 %(-$4.45)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.02226%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00004 %($0.01)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: 0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022262 %
  (-$4.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00004 %
  ($0.01)

Key Stats

• Prev. Close: 70.7
• Open: 69.41
• 1-Year Change: -8.49%
• Day's Range: 69.41 - 72.56

Trade RadNet Inc - RDNT

About RadNet Inc.

RadNet, Inc., is a company, which is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates through joint ventures with hospitals, approximately 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Its centers provide physicians to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. In addition, it has a software division to facilitate imaging business. The Company through its subsidiary, eRAD, Inc. sales computerized systems that distribute, display, store and retrieve digital images.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, RadNet Inc. revenues increased 23% to $1.32B. Net income before extraordinary items totaled $17M vs. loss of $14.8M. Revenues reflect Service Fee Revenue increase of 25% to $1.17B, Revenue under capitation arrangements increase of 6% to $148.3M. Net Income reflects Non-cash change in fair value of int. increase from $2.5M (expense) to $21.7M (income).

Equity composition

Common Stock $.0001 Par, 05/11, 200M auth., 37,319,725 issd. Insiders own 33.44%. IPO 7/86, 4M units (1 Common + 1 Warrant) @ $1 by RooneyPace. 11/06, Co. acq. Radiologix, Inc @ 1 share & $1.79 shr (22,442,417 shs issd.). 11/06, 1-for-2 reverse stock split. 02/07, Exchange changed from OTC Bulletin Board to NASDAQ.